Task: Answer Verification
Input (English): Question: Is large prostate gland size a contraindication to low-dose-rate brachytherapy for prostate adenocarcinoma?
Answer: In men with large prostates, the PSI provides biochemical control and temporal changes in genitourinary toxicity that are comparable with men having smaller glands. Accurate dose optimization and delivery of PSI provides the best clinical outcomes regardless of gland size.
Output (English): no